CTOs on the Move

Context Therapeutics

www.contexttherapeutics.com

 
Context Therapeutics Inc. (Nasdaq: CNTX) is a women`s oncology company developing advanced small molecule and immunotherapy treatments to transform care for hormone-driven breast and gynecological cancers. The Company`s robust clinical program for lead candidate onapristone extended release (ONA-XR) comprises three Phase 2 clinical trials and one Phase 1b/2 clinical trial in hormone-driven breast, ovarian and endometrial cancer, as well as two Phase 0 biomarker pharmacodynamic trials in breast cancer. ONA-XR is a novel small molecule under development as a complete antagonist of the progesterone receptor, a key unchecked mechanism in hormone-driven women`s cancers.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Similar Companies

Concept Matrix Solutions

Concept Matrix Solutions is a company that specializes in the formulation, development, and manufacturing of novel drug delivery systems utilizing CBD from Industrial Hemp and other cannabinoids, as well as Nutraceuticals. They also provide the highest...

Epic Care

We are a dynamic organization committed to providing compassionate, high-quality healthcare across the Northern California East Bay.

Protemix

Protemix is a San Diego, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Institutional Pharmacy Solutions

Institutional Pharmacy Solutions is a Montgomery, AL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Deltanoid Pharmaceuticals

Deltanoid Pharmaceuticals is a Madison, WI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.